Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-09-07

Clinical Trial Update: Preoperative CRT With Capecitabine ± Temozolomide in Patients With LARC [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update investigating preoperative chemoradiation with capecitabine with or without temozolomide in advanced rectal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Capecitabine (capecitabine)
  • Temozolomide (Temozolomide)

Snippet

Sponsor: Asan Medical Center | Conditions: Advanced Rectal Cancer | Phase 2 | Status: COMPLETED